Description
Added on the 06/05/2021 10:03:03 - Copyright : AFPTV - First images
Tehran (Iran), Dec 22 (EFE / EPA), (Camera: Abedin Taherkenareh).- Iranians complain that the country's government has not yet requested the Covid-19 vaccine to any foreign country. According to local media, Iranian authorities have announced that the locally manufactured vaccine could be ready in spring 2021. FOOTAGE OF TEHRAN.
Hamburg (Germany), Dec 18 (EFE / EPA) .- (Germany: Focke Strangmann) The Hamburg fairgrounds, the city's only vaccination centre, is preparing to begin vaccinating the population. Official news after 33,777 new infections with coronavirus and 813 deaths were registered in Germany in the last 24 hours.FOOTAGE OF THE VACCINATION CENTRE.
An FDA advisory committee will meet next month to discuss an emergency use authorization. The emergency use authorization would be for Pfizer's COVID-19 vaccine. Earlier this week, Pfizer said clinical trials had shown its vaccine to be 95% effective. "While we cannot predict how long the FDA's review will take, the FDA will review the request as expeditiously as possible, while still doing so in a thorough and science-based manner," FDA Commissioner Stephen M. Hahn In October, the Emergency Care Research Institute warned against releasing a vaccine. They said six months of follow-up data on clinical trial participants is needed to move forward.
Beijing, Sep 24 (EFE), (Camera: Javier García).- A Covid-19 vaccine currently in the advanced stages of testing will be ready for mass public use by early next year, the president of Chinese pharmaceutical firm Sinovac Biotech said Thursday.Yin Weidong told Efe and other media on a tour of Sinovac’s laboratories and factory in Beijing that the company had the capacity to produce 300 million doses of the vaccine, called CoronaVac, each year.Sinovac began constructing a specialized research laboratory for Covid-19 immunization in March and has been producing the potential future vaccine for several weeks.Yin said researchers explored seven different methods of vaccination and found that the use of the “inactivated vaccine” had proven to be the most effective.He said that phase III testing in subjects over 18-years-old had not shown any side-effects and that the vaccine was capable of immunizing all the variations of SARS-Cov-2 in the world.FOOTAGE OF SINOVAC BIOTECH.SOUNDBITES OF YIN WEIDONG, PRESIDENT OF SINOVAC:"We estimate that the vaccine can be applied to the general population early next year."
The premier of Ontario announces that he will lift vaccine passport requirements in the Canadian province, the epicenter of protests against Covid-19 health measures for more than two weeks now. SOUNDBITE